NCT04906356Recruiting
Canadian SCAD Study
Canadian Spontaneous Coronary Artery Dissection (SCAD) Study and Genetic Sub-study (Prospective, Observational Registry With 10 Year Follow-up)
Source: ClinicalTrials.gov · Last updated 28 May 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Natural history multicenter, prospective, observational registry with 10-year follow-up
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 16 Apr 2021
- Start date
- 1 Dec 2018
- Primary completion date
- 1 Dec 2033
- Lead sponsor
- Cardiology Research UBC
- Diseases
- Coronary artery disease
- NCT number
- NCT04906356
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 1 Dec 2018 to the primary completion date, 1 Dec 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. Patients where SCAD is attributed to atherosclerotic coronary artery disease, with atherosclerotic coronary artery disease stenosis ≥50%
Who the study is looking for
- Patients admitted with ACS (STEMI, NSTEMI or unstable angina)
- Documented SCAD on a coronary angiogram (including diagnosis with OCT or IVUS)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vancouver General Hospital Coordinator of this site? Confirm its status | Vancouver | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.